Amphastar Pharmaceuticals, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
03209R103
SEDOL
BNFWZS4
CIK
0001297184
www.amphastar.com
LEI:
©
FIGI: BBG000BW90S6
AMPH
Amphastar Pharmaceuticals, Inc.
GICS: 35202010 · Sector: Healthcare · Sub-Sector: Drug Manufacturers—Specialty & Generic
NAME
Amphastar Pharmaceuticals, Inc.
ISIN
US03209R1032
TICKER
AMPH
MIC
XNAS
REUTERS
AMPH.OQ
BLOOMBERG
AMPH US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
TradingView ActivTrader MT4 MT5

The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by AccessWire.

Wed, 13.11.2024       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 3:30 pm GMT. For ...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Wed, 06.11.2024       Amphastar Pharmaceuticals
US03209R1032

Reports Net Revenues of $191.2 Million for the Three Months Ended September 30, 2024RANCHO CUCAMONGA, CA / ACCESSWIRE / November 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2024.Third quarter HighlightsNet revenues of $191....
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Tue, 29.10.2024       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESSWIRE / October 29, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2024 ended September 30, 2024, after the market closes on Wednesday, November 6, 2024, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Tim...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements